Male Acne Hormone Panel

The male acne hormone panel is a blood test that measures DHEA-S, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and free testosterone. It may be considered when acne occurs together with additional symptoms, medication exposure, or clinical findings that raise a specific concern about hormonal or endocrine function.

Acne in men is usually diagnosed from the appearance, distribution, and severity of skin lesions rather than from a broad set of laboratory tests. A dermatologic examination is therefore often more important than hormone testing. Laboratory evaluation is most useful when the medical history or examination identifies additional signs that make a targeted hormonal assessment clinically relevant.

What the male acne hormone panel measures

The panel combines four hormone measurements that provide information about adrenal androgen production and signaling within the pituitary and testicular hormonal axis:

• DHEA-S: an androgen produced mainly by the adrenal glands. The result may help assess whether adrenal androgen production should be considered in the wider clinical picture.
• FSH: a pituitary hormone involved in testicular function and sperm production. It is not a direct acne marker, but it may help place other hormonal findings in context.
• LH: a pituitary hormone that stimulates testosterone production in the testes. Its value is interpreted together with symptoms and other hormone results.
• Free testosterone: the fraction of testosterone that is not tightly bound to transport proteins and is more readily available to tissues.

These measurements should not be interpreted as four separate explanations for acne. They are assessed together and compared with the patient’s age, symptoms, medications, supplements, medical history, and physical findings.

Why a dermatologic examination often comes first

Hormones influence sebaceous gland activity, but acne does not automatically mean that blood hormone concentrations are abnormal. Many men with acne do not need endocrine testing. The first assessment usually focuses on the type of lesions, affected areas, severity, duration, scarring risk, previous treatment, skin care products, and possible medication-related triggers.

A dermatologic examination can also distinguish acne from folliculitis, rosacea, medication-related eruptions, inflammatory skin conditions, and other disorders that may resemble acne. This distinction is important because these conditions do not follow the same diagnostic or treatment pathway.

For persistent, painful, nodular, widespread, or scarring acne, timely dermatologic assessment may be more useful than ordering several laboratory panels without a defined clinical question. Laboratory testing can then be selected according to the findings rather than used as a general screening tool.

When targeted hormonal testing may be considered

The panel may be discussed when acne is unusually severe, develops suddenly, begins at an atypical age, does not respond as expected to appropriate treatment, or appears together with signs that could justify a closer review of hormonal function.

Additional information that may influence the decision to test includes:

• current or recent testosterone therapy, anabolic steroid use, DHEA supplements, or other hormone-related products
• unexpected changes in libido, erectile function, fertility, body hair, breast tissue, or muscle development
• known pituitary, adrenal, or testicular disease
• other abnormal hormone findings
• symptoms that lead a doctor to suspect a broader endocrine disorder

The appropriate laboratory workup depends on the additional signs. This four-test panel may answer a defined question in some patients, while others may require different or additional tests. A normal panel also does not exclude every hormonal, medication-related, or dermatologic factor that could contribute to acne.

How the testing pathway usually works

Step 1: Review of acne and additional symptoms

The process should begin with a clear description of when the acne started, which areas are affected, how quickly it has changed, whether painful nodules or scarring are present, and which treatments have already been tried. Current medications, hormone therapy, anabolic substances, supplements, and skin care products should also be reported.

Step 2: Deciding whether laboratory testing is useful

A clinician considers whether the acne pattern and accompanying signs support hormone testing. When acne is the only concern and the skin findings are typical, a dermatologic treatment plan may be the more relevant next step. When additional endocrine signs are present, the panel may provide useful supporting information.

Step 3: Preparation for blood sampling

The test is performed from a venous blood sample. Morning collection may be recommended because some hormone concentrations vary during the day. Patients should follow the preparation instructions provided for the appointment and confirm whether fasting is required. Prescribed medication should not be stopped without medical advice.

Step 4: Blood collection and laboratory analysis

A healthcare professional collects the blood sample during one venipuncture. The sample is analyzed for DHEA-S, FSH, LH, and free testosterone. The collection itself usually takes only a few minutes.

Step 5: Interpretation and next steps

The report shows the measured values and the applicable laboratory reference intervals. Results should be reviewed together rather than interpreted from a single number. Depending on the findings, the next step may be dermatologic treatment, medication review, repeat testing, additional endocrine evaluation, or no further hormonal testing.

What the results can and cannot show

The panel can identify values outside the applicable reference intervals and help a doctor assess whether selected parts of adrenal or reproductive hormone function require further attention. It cannot diagnose the cause of acne on its own, determine which acne treatment will work, or replace examination of the skin.

Reference intervals may vary according to the analytical method, age, sampling time, and laboratory. Results near or outside a reference limit do not automatically prove that a hormonal disorder is causing acne. Conversely, acne may still be influenced by androgen activity even when measured values are within the stated range.

Interpretation is particularly important when the patient uses testosterone, anabolic steroids, DHEA, fertility medication, corticosteroids, or supplements that may affect hormone measurements or the clinical picture.

Practical next step through ZagrebMed

Before sending an inquiry, prepare a short description of the acne, the age at which it began, affected areas, previous treatments, current medications and supplements, and any additional hormonal or sexual health symptoms. Photographs of the skin and previous dermatology or laboratory reports may also help clarify whether a dermatologic examination, this panel, or another targeted evaluation is the more appropriate next step.

You can send this information through ZagrebMed to request guidance on organizing the relevant examination or laboratory service in Zagreb without ordering a broad set of tests without a clear clinical reason.